Litcius/Paper detail

Skin manifestations in patients with coronavirus disease 2019

Matteo Bassetti, Cesare Massone, Antonio Vena, Silvia Dettori, Claudio Conforti, Daniele Roberto Giacobbe, Iris Zalaudek

2022Current Opinion in Infectious Diseases18 citationsDOIOpen Access PDF

Abstract

PURPOSE OF REVIEW: Coronavirus disease 2019 (COVID-19) is a well established respiratory tract illness. Recent studies in adults and children have shown an increasing number of patients reporting polymorphic cutaneous manifestations during COVID-19, including different types of rashes, from maculopapular, vascular, vesicular to atypical forms. RECENT FINDINGS: Although pathogenesis of skin manifestations is still not fully understood, it has been proposed that cutaneous involvement during COVID-19 may be the results of the activation of the immune response against severe acute respiratory syndrome coronavirus-2, the reactivation or co-infection of herpesviruses or drug hypersensitivity. SUMMARY: According to available literature, skin manifestations in patients with COVID-19 may be categorized on the basis of their clinical presentations as follows: erythematous rashes, lesions of vascular origin, vesicular rash, urticarial rash and acute generalized exanthematous pustulosis (AGEP), erythema multiforme and other polymorphic erythema/atypical reactions. Prompt recognition of these cutaneous manifestations represents a crucial point to facilitate diagnosis and management of COVID-19 patients.

Topics & Concepts

MedicineErythema multiformeDermatologyRashCoronavirus disease 2019 (COVID-19)Acute generalized exanthematous pustulosisErythemaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Skin lesionMultisystem disease2019-20 coronavirus outbreakPustulosisDiseaseExanthemCellulitisErythema chronicum migransCoronavirusCutaneous VasculitisDermatological and COVID-19 studiesDrug-Induced Adverse ReactionsCOVID-19 Clinical Research Studies
Skin manifestations in patients with coronavirus disease 2019 | Litcius